Status:

UNKNOWN

Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer

Lead Sponsor:

Loyola University

Collaborating Sponsors:

Cures Within Reach

Medical University of South Carolina

Conditions:

Ovarian Cancer

Eligibility:

FEMALE

18-90 years

Phase:

PHASE2

Brief Summary

The primary purpose of this study is to determine the response rate of patients with recurrent platinum resistant ovarian cancer when treated with oral minoxidil. Secondary objectives include estimati...

Detailed Description

Minoxidil is approved by the Food and Drug Administration (FDA) for treatment of hypertension. In previous studies, the sulfonylurea receptor (SUR) subunit controls the selectivity of the pharmacologi...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Participants must have recurrent platinum resistant ovarian cancer. Histologic documentation of the recurrence is not required.
  • Participants must have platinum resistant disease defined as recurrence less than 6 months after initial platinum based treatment.
  • Participants must be greater than or equal to 18 years of age.
  • Participants must have an Eastern Cooperative Group (ECOG) Performance Status (PS) less than or equal to 2.
  • Participants must be able to take oral medications.
  • Exclusion Criteria
  • Participants must not have had chemotherapy or radiotherapy within 4 weeks
  • Participants must not be receiving any other investigational agents.
  • Participants must not have brain metastases
  • Participants must not have allergic reactions to minoxidil
  • Participants must not have congestive heart failure
  • Participants must not have history of cardiac disease
  • Participants must not have uncontrolled hypertension
  • Participants must not be on dialysis

Exclusion

    Key Trial Info

    Start Date :

    December 13 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2024

    Estimated Enrollment :

    34 Patients enrolled

    Trial Details

    Trial ID

    NCT05272462

    Start Date

    December 13 2021

    End Date

    December 31 2024

    Last Update

    October 5 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Loyola University Medical Center

    Maywood, Illinois, United States, 60153